Oxford, UK: Genomics plc (“Genomics”), a leading analysis company developing algorithms, data resources, and software solutions to uncover the relationships between genetic variation and human disease, today announced that Vertex Pharmaceuticals will use Genomics’ integrated database and state-of-the-art analysis tools to inform its drug research and development. These tools aim to provide confidence in the […]
Bluebee and the Bioinformatics Core Facility at the CECAD Research Center of the University of Cologne are collaborating to implement QuickNGS on Bluebee’s high-performance cloud platform for genomic analysis. In a society where people are living longer, the Cologne Cluster of Excellence (CECAD) at the University of Cologne explores aging-associated disorders and their causes. More […]
South Plainfield, NJ –– Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS). “The genomic services business of Beckman Coulter is an ideal fit with GENEWIZ’s […]
Scientists at TGAC have been putting Oxford Nanopore’s MinION sequencer through its paces with an open-source, sequence alignment-based genome analysis tool called ‘NanoOK’. NanoOK is the first open-source tool that provides comprehensive alignment-based quality control and error profile analysis for the MinION platform. NanoOK’s main output is a detailed PDF report featuring graphs and tables […]
The advent of Next Generation Sequencing (NGS) has revolutionised rare disease genomic research, to improve diagnosis and discover novel causative genes. UCB, a global biopharmaceutical leader, is harnessing these advances to unpick the mechanisms behind novel rare diseases as a means for better understanding fundamental biological processes. UCB’s goal is to transform this insight into […]
GAINESVILLE, Fla. and BOCA RATON, Fla. — The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with RAPiD Genomics a Gainesville-based company with technology licensed from the University of Florida. The Institute supports new company creation based on publicly-funded research, and bridges early funding […]
Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed three additional non-exclusive distribution agreements with PhileKorea, Pharma Tech Korea and Axil Scientific for the commercialization of SYGNIS’ proprietary product portfolio in Korea and Singapore and thereby significantly expands its Asian footprint. With these agreements, […]
LAUSANNE, Switzerland – Sophia Genetics, the global leader in Data Driven Medicine (DDM), today announced the closing of a new $15 million Series C financing round led by Omega founder and healthcare scion Marc Coucke. The funds will be used to continue Sophia’s rapid market expansion and broaden its range of genomic tests. Witnessing a […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc., (Nasdaq:PACB) a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, announced that the company has received ISO 13485 and ISO 9001 certifications for the design, development, manufacture, distribution, installation, and servicing of its nucleic acid sequencing platforms. The International Organization for […]
Beijing & San Diego — Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of genomic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
